Microenvironmental independence associated with tumor progression

Cancer Research

Volumn 69, Issue 22, 2009, Pages 8797-8806

  Anderson, Alexander R A ^a   Hassanein, Mohamed ^b   Branch, Kevin M ^b   Lu, Jenny ^b   Lobdell, Nichole A ^b   Maier, Julie ^b   Basanta, David ^a   Weidow, Brandy ^b   Narasanna, Archana ^c   Arteaga, Carlos L ^c   Reynolds, Albertb ^b   Quaranta, Vito ^b   Estrada, Lourdes ^b   Weaver, Alissa M ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; PHENOTYPIC VARIATION; PRIORITY JOURNAL; TUMOR GROWTH;

BREAST NEOPLASMS; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; GAME THEORY; HUMANS; MODELS, THEORETICAL;

EID: 71549133777     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0437     Document Type: Article

References (48)

1. Witz IP. Yin-yang activities and vicious cycles in the tumor microenvironment. Cancer Res 2008;68:9-13.
2. Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006;127:905-915 (Pubitemid 44792251)
3. Anderson ARA. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005;22:163-186
4. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30:256-268 (Pubitemid 36677560)
5. Santner SJ, Dawson PJ, Tait L, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001;65:101-110 (Pubitemid 32193613)
6. Huen AC, Park JK, Godsel LM, et al. Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol 2002;159:1005-1017
7. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007;67:4227-4235
8. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, Weaver AM. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 2005;15: 1276-1285
9. Potdar AA, Lu J, Jeon J, Weaver AM, Cummings PT. Bimodal analysis of mammary epithelial cell migration in two dimensions. Ann Biomed Eng 2009;37:230-245
10. Bargmann CI, Hung MC, Weinberg RA. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986;45:649-657
11. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003;114:33-45.
12. Sabeh F, Ota I, Holmbeck K, et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004;167:769-781 (Pubitemid 39565156)
13. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006;66:3034-3043
14. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006;23:97-105. (Pubitemid 44440169)
15. Friedl P, Wolf K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res 2008;68:7247-7249
16. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006;4:38.
17. Gatenby RA, Smallbone K, Maini PK, et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 2007;97:646-653 (Pubitemid 47339892)
18. Gerlee P, Anderson ARA. An evolutionary hybrid cellular automaton model of solid tumour growth. J Theor Biol 2007;246:583-603. (Pubitemid 46719261)
19. Fisher RA. The wave of advance of advantageous genes. Ann Eugenics 1937;7:355-369
20. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
21. Smalley KS, Brafford PA, Herlyn M. Selective evolutionary pressure from the tissue microenvironment drives tumor progression. Semin Cancer Biol 2005;15: 451-459 (Pubitemid 41318045)
22. Kam Y, Karperien A, Weidow B, Estrada L, Anderson AR, Quaranta V. Nest expansion assay:a cancer systems biology approach to in vitro invasion measurements. BMC Res Notes 2009;2:130.
23. Maynard Smith J. Evolution and the theory of games. Cambridge; New York: Cambridge University Press; 1982.
24. Basanta D, Deutsch A. A game theoretical perspective on the somatic evolution of cancer. In: Bellomo N, editor. Selected topics on cancer modeling: genesis, evolution, immune competition, therapy. Boston: Birkhauser; 2008.
25. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-141
26. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-850 (Pubitemid 40558990)
27. Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004;4:978-987
28. Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008;9:702-712
29. Staib F, Robles AI, Varticovski L, et al. The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res 2005;65:10255-10264 (Pubitemid 41743717)
30. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005; 173:10-20. (Pubitemid 39627663)
31. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
32. Rubin H. Microenvironmental regulation of the initiated cell. Adv Cancer Res 2003;90:1-62.
33. Dormann S, Deutsch A. Modeling of self-organized avascular tumor growth with a hybrid cellular automaton. In Silico Biol 2002;2:393-406. (Pubitemid 35469212)
34. Drasdo D, Hohme S. A single-cell-based model of tumor growth in vitro: monolayers and spheroids. Phys Biol 2005;2:133-147 (Pubitemid 41483079)
35. Jiang Y, Pjesivac-Grbovic J, Cantrell C, Freyer JP. A multiscale model for avascular tumor growth. Biophys J 2005;89:3884-3894 (Pubitemid 41725610)
36. Rejniak KA. A single cell approach in modeling the dynamics of tumor microregions. Math Biosci Eng 2005;2:643-655
37. Stott E, Britton NF, Glazier JA, Zajac M. Stochastic simulation of benign avascular tumor growth using the Potts model. J Theor Biol 1999;30:183-198 (Pubitemid 29449832)
38. Turner S, Sherratt JA. Intercellular adhesion and cancer invasion: a discrete simulation using the extended Potts model. J Theor Biol 2002;216:85-100. (Pubitemid 34748059)
39. Zhang L, Athale CA, Deisboeck TS. Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor Biol 2007;244:96-107. (Pubitemid 44751755)
40. Poplawski NJ, Agero U, Gens JS, Swat M, Glazier JA, Anderson AR. Front instabilities and invasiveness of simulated avascular tumors. Bull Math Biol 2009;71:1189-1227
41. Jones S, Chen WD, Parmigiani G, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci US A 2008;105:4283-4288 (Pubitemid 351754372)
42. Beerenwinkel N, Antal T, Dingli D, et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007;3:e225.
43. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823.
44. Ramis-Conde I, Drasdo D, Anderson AR, Chaplain MA. Modeling the influence of the E-cadherin-β-catenin pathway in cancer cell invasion: a multiscale approach. Biophys J 2008;95:155-165
45. Rejniak KA. An immersed boundary framework for modelling the growth of individual cells: an application to the early tumour development. J Theor Biol 2007;247:186-204.
46. Rejniak KA, Anderson ARA. A computational study of the development of epithelial acini: I. Sufficient conditions for the formation of a hollow structure. Bull Math Biol 2008;70:677-712.
47. Chang TH, Szabo E. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-γ and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin Cancer Res 2002;8:1206-1212 (Pubitemid 35177376)
48. Nowak D, Stewart D, Koeffler HP. Differentiation therapy of leukemia-three decades of development. Blood 2009; 113:3655-3665